2-{[3-Methyl-4-(2,2,2-trifluoro­eth­oxy)pyridin-2-yl]methyl­sulfan­yl}-1H-benzimidazole monohydrate: a monoclinic polymorph

por Chen, Yu-Feng, Chen, Jin-Yao, Hong, Ming-Huang, Lu, Jie, Ren, Guo-Bin
Publicado 2012

2-{[3-Methyl-4-(2,2,2-trifluoro­eth­oxy)pyridin-2-yl]methyl­sulfan­yl}-1H-benzimidazole propan-2-ol monosolvate: a second monoclinic polymorph

por Ma, Jin-Ju, Qi, Ming-Hui, Hong, Ming-Huang, Lu, Jie, Ren, Guo-Bin
Publicado 2012

2-{[3-Methyl-4-(2,2,2-trifluoro­eth­oxy)pyridin-2-yl]methyl­sulfan­yl}-1H-benzimidazole monohydrate

por Ren, Guo-Bin, Hong, Ming-Huang, Zhong, Jia-Liang, Yi, Dong-Xu, Xu, Le-Hui
Publicado 2011

1,3-Dihy­droxy-2-(hy­droxy­meth­yl)propan-2-aminium formate

por Ren, Guo-Bin, Qi, Ming-Hui, Chen, Jin-Yao, Meng, Kun-Yan, Zhong, Jia-Liang
Publicado 2011

Development of a gliclazide ionic liquid and its mesoporous silica particles: an effective formulation strategy to improve oral absorption properties

por Zhou, Bijian, Teng, Dan, Li, Jinghui, Zhang, Yanhong, Qi, Minghui, Hong, Minghuang, Ren, Guo-Bin
Publicado 2022